Three Dimensional Ultrasonographic Detection of Human Ovulation
Three Dimensional Ultrasonographic Detection of Human Ovulation and Anovulation
University of Saskatchewan
30 participants
Apr 22, 2024
INTERVENTIONAL
Conditions
Summary
The research aims to compare diagnosis of ovulation and anovulation in 2D and 3D ultrasonography.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The medication is commenced when a preovulatory follicle is observed. It will be administered for a minimum of one day, up to a maximum of 7 days. It will be discontinued when anovulation is observed.
Ultrasound scans done intermittently before and after an ovulatory or anovulatory event
Capillary blood extracted from a finger prick. Blood spots are collected on a specialized card, dried and frozen before reproductive hormones are assayed from them.
Early morning urine tests to assay reproductive hormones
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06433453